This work sought to identify a non-invasive means to detect pulmonary arterial hypertension (PAH). 129Xenon MRI and dynamic spectroscopy were acquired in healthy volunteers and subjects with chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), left heart failure (LHF), and PAH. COPD was differentiated from PAH by increased ventilation and barrier defects, while IPF was differentiated by increased barrier uptake. PAH and LHF subjects had similar imaging features but could be differentiated by their RBC signal oscillation amplitudes. 129Xe MR imaging and spectroscopy appears capable of differentiating PAH from COPD, IPF, and LHF.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords